Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

Clinical trial NCT06051123 · RECRUITING

Trial details

NCT number: NCT06051123
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

ALSFTD ALS (Amyotrophic Lateral Sclerosis)Frontal Temporal Dementia (FTD)

Start date: 2024-01-01
Primary completion: 2027-02-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.